SS Innovations Appoints Sarah Romano as CFO to Lead Financial Strategy Amid U.S. FDA Approval Pursuit

July 14th, 2026 1:49 PM
By: Newsworthy Staff

SS Innovations International, Inc. has appointed Sarah M. Romano as CFO, leveraging her extensive finance leadership in medtech to support global expansion and FDA approval for the SSi Mantra surgical robotic system.

SS Innovations Appoints Sarah Romano as CFO to Lead Financial Strategy Amid U.S. FDA Approval Pursuit

SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano, who is based in the United States, brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.

The appointment comes at a critical time for SS Innovations, which is working to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company plans to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary SSi Mantra surgical robotic system and the comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.

Romano's extensive experience in raising capital and managing financial operations will be instrumental as SS Innovations pursues regulatory approvals in the United States and other key markets. The company, headquartered in India but incorporated in the United States, aims to leverage its innovative technologies to compete in the global surgical robotics market.

For more information about SS Innovations and its latest news, visit the company's newsroom at https://ibn.fm/SSII.

Source Statement

This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,

blockchain registration record for the source press release.
;